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Abstract.  Fibroblast caldesmon is a protein postulated 
to participate in the modulation of the actin cytoskele- 
ton and the regulation of actin-based motility.  The 
cDNAs encoding the NH2-terminal (aa.1-243,  CAD40) 
and COOH-terminal  (aa.244-538,  CAD39)  fragments 
of human caldesmon were subcloned into expression 
vectors and we previously reported that bacterially 
produced CAD39 protein retains its actin-binding  prop- 
erties as well as its ability to enhance low Mr 
tropomyosin (TM) binding to actin and to inhibit TM- 
actin-activated HMM ATPase activity in vitro (Novy, 
R. E., J.  R.  Sellers,  L.-E  Liu, and J. J.-C.  Lin.  1993. 
Cell Motil.  Cytoskeleton.  26:248-261).  Bacterially 
produced CAD40 does not bind actin.  To study the in 
vivo effects of CAD39 expression on the stability of 
actin filaments in CHO ceils, we isolated and charac- 
terized stable CHO transfectants which express vary- 
hag amounts of CAD39. We found that expression of 
CAD39 in CHO cells stabilized microfilament bundles 
as well as endogenous TM.  CaD39-expressing clones 
displayed an increased resistance to cytochalasin B 
and Triton X-100 treatments and yielded increased 
amounts of TM-containing  actin filaments in microfila- 
merit isolation procedures. In addition,  analysis of 
these clones with immunoblotting and indirect im- 
munofluorescence microscopy with anti-TM antibody 
revealed that stabilized endogenous TM and enhanced 
TM-containing microfilament bundles parallel in- 
creased amounts of CAD39 expression.  The increased 
TM observed corresponded to a decrease in TM turn- 
over rate and did not appear to be due to increased 
synthesis of endogenous TM.  Additionally, the 
phenomenon of stabilized TM did not occur in stable 
CHO clones expressing CAD40. Therefore, it is likely 
that CAD39 can enhance TM's binding to F-actin in 
vivo, thus reducing TM's rate of turnover and stabiliz- 
ing actin microfilament bundles. 
C 
ALDESMON is an actin-,  myosin-, tropomyosin-,  and 
Ca++/Calmodulin-binding  protein  found  on  actin- 
based filaments  of smooth muscle and  nonmuscle 
cells (for reviews see Sobue and Sellers,  1991; Marston and 
Redwood, 1991; Matsumura and Yamashiro, 1993). Though 
the smooth muscle and nonmuscle forms differ in molecular 
weight due to the presence of a  central  repeat region in 
smooth muscle caldesmon (Hayashi  et al.,  1991; Sobue et 
al.,  1988),  they exhibit  similar  properties in vitro.  These 
properties include the ability to bind myosin (Marston et al., 
1992), to bind actin,  and enhance tropomyosin (TM) 1  bind- 
ing to actin, and to inhibit the ATPase activity of actomyosin 
(Sobue et al., 1988; Yamashiro-Matsumura  and Matsumura, 
1988;  Sobue and  Sellers,  1991; Marston  and  Redwood, 
1991; Matsumura and Yamashiro, 1993), all in a manner that 
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is reversibly regulated by Ca++/Calmodulin (Hayashi et al., 
1991) and caldesmon's phosphorylation state (Yamashiro et 
al.,  1990;  Yamashiro  and Matsumura,  1991; Mak et al., 
1991). In addition,  nonmuscle caldesmon has been shown to 
improve TM's ability to protect actin from gelsolin severing 
and capping  (Ishikawa et al.,  1989a,b). Even though these 
interactions  have been well characterized in vitro, the func- 
tions of caldesmon in the living cell have yet to be assigned. 
There are several reports, consistent with in vitro observa- 
tions, which suggest in vivo roles for nonmuscle caldesmon 
in the modulation/stabilization  of actin microfilaments,  and 
in the regulation  of intracellular  granular  movement and 
secretion.  For example, Hegnaann et al. (1991) demonstrated 
that  microinjection  of a  monoclonal anti-caldesmon  anti- 
body, which interferes with caldesmon's ability to bind actin, 
drastically reduced intracellular  granular movement in chick 
embryo fibroblasts.  In pituitary gonadotrophs,  the injection 
of an anti-caldesmon  antibody,  which disrupts caldesmon- 
actin  interactions,  led to a  decrease in detectable F-actin 
bundles and an increase in hormone-stimulated release of 
gonadotropin  (Janovick et al.,  1991). Additionally,  the glu- 
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pituitary cells accompanied the actin filament  stabilization 
responsible for the inhibition of leutenizing hormone release 
(Castellino et al., 1992). More evidence to suggest that non- 
muscle caldesmon affects microfilament stability and organi- 
zation  comes from reports that  document mitosis-specific 
phosphorylation of caldesmon, and caldesmon's  subsequent 
release  from  microfilaments  during  mitotic  cytoskeletal 
remodeling  (Yamashiro et al.,  1990; Hosoya et al.,  1993). 
Many transformed lines also show a reorganized,  diminished 
actin cytoskeleton, and such transformed lines also demon- 
strate  a  reduction in caldesmon expression (Novy et al., 
1991; Owada et al.,  1984). 
To directly study the function of human nonmuscle caldes- 
mon, we have subcloned cDNAs encoding the NH2-terminal 
fragment  (CAD40, aa.1-243) and the COOH-terminal frag- 
ment (CAD39, aa.244-538) of human nonmuscle caldesmon 
into prokaryotic and eukaryotic expression vectors. As pre- 
viously reported (Novy et al., 1993b), bacterially produced 
CAD39 protein,  which contains actin,  TM, and Ca++/Cal  - 
modulin-binding  domains (see Fig.  1), retained the abilities 
to bind actin, potentiate  TM binding to actin,  and to inhibit 
actin-TM-activated  myosin  ATPase  activity.  Bacterially 
made CAD40 protein displayed no actin binding.  The differ- 
ence in actln-binding ability between the two CaD fragments 
was also seen in in vivo experiments  with DNA  transfec- 
tions, and, in this paper, we report that expression of CaD39 
in CHO cells, via stable transfection,  stabilizes  endogenous 
TMs and actin microfilament  bundles. 
Materials and Methods 
Plasmid DNA Constructs 
cDNAs  encoding  the  NH2-terminal  fragment  (CAD40,  aa.1-243)  and 
COOH-terminal fragment (CAD39, aa. 244-538) of human fibroblast cai- 
desmon (see Fig.  1, Novy et ai.,  1991) from pETCaD40 and pETCaD39, 
respectively  (Novy et ai., 1993b), were subeloned into the XbaI site of the 
eukaryotic expression vector pCB6b.x, a modified version of pCB6 (kindly 
provided by Dr. M. Stinsld, The University of Iowa). The modification  re- 
moved a DNA sequence from the polylinker region that contained an ATG 
predicted to cause unwanted translation initiation. The pCB6hx expression 
vector contains the neo  r gene to allow  for selection in the presence of 
G418, a synthetic neomycin.  Recombinant CaD fragment-containing plas- 
raids are referred to as pCBCaD39 and pCBCaD40. 
Cell Culture and Transfection 
CHO cells were grown in DMEM plus 10% FCS and were kept in a 37°C 
humidified incubator with 5% CO2. DNA transfection was performed via 
calcium phosphate coprecipitation, as described (Lourim and Lin, 1992). 
Plasmid DNA was prepared with Qiagen columns according to manufac- 
turer's direction (Qiagen Inc., Cbatsworth,  CA). 
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Figure 1.  Schematic cartoon of human fibroblast caldesmon frag- 
ments CAD40 and CAD39,  including the proposed  binding sites 
residing  in  each  fragment.  (for  detail  see  Matsumura  and 
Yamashiro,  1993.) 
For transient transfections,  cells were assayed by immunoflnorescence  at 
18-24  h  after transfection.  For the establishment of stably expressing 
CAD39 and CAD40 lines, cells at one day after transfection, were selected 
for in DMEM plus 10% FCS with 500 ~f,/mi CO,18 (GIBCO BRL Gaithers- 
burg,  MD). After 2 wk of selection, single cells were cloned, expanded, 
and tested for CAD39 or CAD40 expression.  Stable lines 39L12,  39(211, 
39C15  and 40Cll,  40C22,  40C7,  and 40C17, expressing  low  to  high 
amounts of CAD39 or CalM0, respectively,  were obtained for use in this 
study. Nonexpressing,  G418-resistant lines 39C5 and 40N2 were isolated 
for use as controls. 
Monoclonal Antibodies 
Anti-TM5  tropomyosin  antibody CG3 and anti-caddesmon  antibody C21 
were prepared and characterized previously (Lin et al., 1985, 1988, 1991). 
C21 recognizes an epitope in the COOH-terminal half of cuidesmon that 
is highly conserved between human, rat, and chicken caldesmon (Novy et 
al., 1991). C21 cross-reacts with both CAD39 and endogenous CHO caldes- 
mon, although the naturally low levels of endogenous  CHO caldesmon al- 
lowed detection of CAD39 alone when 1,000-fold dilutions of C21 ascites 
fluid were used for immunofluorescence  micro-~x~py of transfec~ cells. 
For detection of endogenous caldesmon, C21 was used at 250-fold dilution. 
CaD40-specific  monoclonal antibody C57 was generated for use in this 
study by immunizing mice with purified bacterially produced CAD40 pro- 
tein. Generation of C57 followed procedures described (Lin et al., 1985). 
C57 antibody was tested for CaD40-immtmospecificity  by ELISA, Western 
blotting, and immunofluorescence.  C57 does not cross-react with CHO cal- 
desmon. C21 and C57 are IgG1 class; CG3 is an IgM class antibody and 
its epitope has been mapped to aa #29-44 of human TM5 (Novy et ai., 
1993b). Broad species-specific  polyclonal  anti-caddesmon was a generous 
gift of Dr.  A. Bretscher,  Cornell University (see Bretscher and Lynch, 
1985). 
Immunofluorescence Microscopy 
Cells were prepared for indirect immunofluorescence  as described (Warren 
and Lin, 1993).  Primary antibodies CG3, C21, C57, and polyclonal anti- 
caldesmon were described above. The secondary antibodies used included 
FITC-conjugated goat anti-mouse IgG (3' chain specific, Sigma Chem. Co., 
St. Louis, MO), TRrrc-conjugated goat anti-mouse IgM ~  chain specific, 
Cappel, Durham, NC), Lissamine-rhodamine-eonjugnted  goat anti~-mouse 
IgG (heavy and light chain, Boehringer Maanheim, Indianapolis,  IN), and 
rhodamine-conjugated  goat-anti-rabbit  IgG (heavy and light chain, Cappel, 
Durham,  NC).  Cells  were  observed and  photographed  using a  Zeiss 
epiflnorescence  photomieroscope nl. 
Cytochalasin B Treatment 
Cells were grown to ,,080% confluency on glass coverslips. Treatment with 
cytochaiasin  B involved exposure to 1.0, 1.25, or 1.5 ~tg/ml cytochalasin B 
for 30 rain at 37°C. Cytochalasin B was solubilized in DMSO before addi- 
tion to the culture dishes, so a DMSO-treated control group of cells were 
also prepared.  Cells were then fixed, acetone permeabilized, and stained 
with CG3 to visualize the remaining TM-containing microfilament bundles. 
Western Blot and SDS-Polyacrylamide 
Gel Electrophoresis 
Cells at 90% confluence  were rinsed three times in wash solution (PBS, 
containing 5 mM MgCI2 and 0.1  mM EGTA),  and then harvested in a 
small volume of 2x gel sample buffer (0.1 M DTT, 2% SDS, 0.08 M Tris 
pH 6.8, 15% glycerol,  0.006% bromophenol blue) and heated for 3 rain at 
100°C. Western immunoblotting, after protein resolution by 12.5%  SDS- 
PAGE, was performed as described (Lin et al., 1985). The antibodies used 
C21, C57, and CG3 were described above. Amido black staining was used 
to determine relative protein loading. 
Pulse Labeling and Two-Dimensional 
Gel Electrophoresis 
Cells cultured to 85-90% confluency were labeled for 4 h with [35S]methi- 
onine (100/~Ci,  1100 Ci/mmol, Amersham Corp., Arlington Heights,  IL) 
in methionine-free DMEM and 2.5% FCS,  and then harvested in 2x gel 
sample buffer. Samples were subjected to two-dimensional  gel electropho- 
resis as described (Lin et ai.,  1984).  Gels were dried and exposed  to 
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CAD39 Cell Lines 
% of total cell extract  Molar Ratio 
Cell lines  CHOCaD  CAD39  CaD39.CHOCaD 
39C5  0.0080  0.0000  0.0 
39L12  0.0080  0.0640  16.3 
391211  0.0086  0.3100  73.4 
39C15  0.0080  0.3100  78.9 
Autoradiographs from C21 immunoblots of purified CAD39 protein standards 
and known quantifies of CAD39 cell extracts were analyzed using Image-1/AT 
software. Data are from a representative experiment, one of two. The Mrs of 
33.4 Kd and 68 Kd for CAD39  and CHOCaD, respectively, were used to calcu- 
late molar ratios. 
X-OMAT  autoradiography  film  (Eastman Kodak  Co.,  Rochester,  NY) 
for3 d. 
Pulse-Chase Experiments 
39C5  and 39C15  cells were pulse-labeled for 25  min with  100 #Ci of 
[35S]methionine in methionine-free DMEM with 2.5% FCS.  To begin the 
chase, the labeling media was quickly replaced with DMEM media contain- 
ing excess methionine (3 mg/ml) and 10% FCS.  Samples  were harvested 
in 2x  sample buffer as described above at 0, 2, 6,  10,  14, and 22 h after 
starting the chase. 2D gel electrophoresis and fluorography were performed 
as described in Linet al., 1984, and gels were then dried on paper and ex- 
posed to X-OMAT  autoradiography film (Eastman Kodak  Co.,  Roches- 
ter, NY). 
Intensity Analysis with Image-I/AT Software 
Images were obtained with a Hamamatsu CCD camera, model XC77, with 
camera controller C2400 (Hamanlatsu,  Hamamatsu-city,  Japan) and ana- 
lyzed using Image-FAT image processing and analysis system, version 4.13 
(Universal Imaging Corporation, West Chester, PA). After autoradiograph 
images were acquired, hand-traced regions representing 1D gel bands or 2D 
gel spots were measured for area enclosed and average gray value. The prod- 
uct (area x  average gray value) minus the background gray value gave the 
relative intensity value. 
For the C21 immunoblot data shown in 1hble I, autoradiograph bands 
from known amounts of purified, bacterially produced CAD39 (Novy et al., 
1993) and their corresponding band intensity values were used to construct 
a  standard curve against which the CAD39 cell extract caldesmon and 
CAD39 autoradiograph bands were measured. For the pulse-chase experi- 
ments graphed in Fig.  8, the gel spots corresponding to TM4, TM5,  and 
a control protein were traced and analyzed for intensity values. The values 
for TM4 and TM5 were plotted against chase time. 
Other Procedures 
The  TM-enriched microfilaments  were  isolated  from  various  CaD39- 
expressing cells (39L12, 39Cll, and 39C15) as well as the non-expressing 
cells (39C5),  as previously  described (Lin et al.,  1984). The yield of iso- 
lated microfilaments  was estimated from [35S]methionine-labeled cells, ac- 
cording to the previously  established method (Lin et al.,  1984),  and ex- 
pressed as the act.in content. The probes for various tropomyosin isoforms, 
and the procedure used for Northern blot analysis  were described p~vi- 
ously (Novy et al.,  1993a). 
Results 
Force-expressed CAD39 Localizes 
to Stress l~bers and Membrane Ruffle Regions 
in CHO Cells 
To determine  if human  caldesmon  fragments  CAD39 and 
CAD40 could display, in vivo, the same binding properties 
seen with bacterially produced fragments in vitro, we tran- 
siently  transfected  CHO  cells with  recombinant  plasmids 
pCBCaD39 or pCBCaD40.  At 24 h  after transfection,  the 
force-expressed CAD39 and CAD40 proteins were visualized 
in the cells with monoclonal antibodies C21,  specific to an 
epitope in the COOH-terminal half of caldesmon, and C57, 
NH2-terminal  specific  antibody.  Consistent  with  in  vitro- 
based predictions,  immunofluorescence microscopy revealed 
that CHO-expressed CAD39 protein is found on stress fibers 
and ruffle regions.  This localization is seen irrespective of 
the level of expression.  Fig. 2 shows the staining pattern of 
CAD39 in transfected cells from two different fields.  Note 
that cytoplasmic staining is also seen in cells expressing high 
amounts of CAD39 (Fig.  2  C), perhaps due to a saturation 
Figure  2.  Transient transfec- 
tion  of  CHO  cells  with 
pCBCaD39.  Imrnunofluores- 
cence  micrographs  of  CHO 
cells,  taken  24  h  after  tran- 
sient  transfection  with 
pCBCaD39  (A  and  C).  The 
corresponding  phase  micro- 
graphs  appear  in  B  and  D. 
Force-expressed CAD39 local- 
izes  to  stress  fibers,  edges, 
and ruffle regions, and, when 
expressed  in  high  amounts, 
also  distributes  within  the 
cytoplasm (C). C21 antibody, 
which  cross-reacts  strongly 
with  CAD39  protein  and 
weakly with endogenous cal- 
desmon, was used at a high di- 
lution to  ensure detection of 
CAD39  alone.  The non-reac- 
tive cells in each field serve as 
a C21  specificity control. Bar 
equals  10 #m. 
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cells in the micrographs serve as controls to show that C21 
antibody, although it recognizes both CAD39 and CHO cal- 
desmon at low dilution, can be suitably used at 1,000x dilu- 
tion to detect CAD39 expression alone. 
Also in agreement with predictions, CAD40 expression in 
CHO cells did not result in a stress fiber staining pattern. 
Fig.  3  immunofluorescence micrographs show transiently 
transfected CHO cells which express CAD40 in low (Fig. 3 
A), medium, or high (Fig. 3 C) amounts. CAD40, which does 
not possess actin or TM-binding sites, distributed throughout 
the cytoplasm and appeared to concentrate in the nucleus. 
The nuclear staining may be a nonspecific consequence of 
CaD40's small size, but, interestingly, CAD40 sequence does 
contain several stretches of positively charged amino acid 
residues, which may serve as a nuclear localization signal 
(for sequence detail, see Novy et al.,  1991). Western blot 
analysis of total cell extracts, harvested after transient trans- 
fection,  revealed  C21-positive  (CAD39) and  C57-positive 
(CAD40) bands at the expected positions after gel electro- 
phoresis (data not shown), indicating that CAD39 and CAD40 
are being expressed in their entirety in these transfection 
experiments. 
Figure 3.  Transient transfection of CHO cells with pCBCaD40 
resulted in a nuclear and cytoplasmic distribution of CAD40 pro- 
rein, as detected by C57 antibody. A and C show immunofluores- 
cence micrographs of CAD40 expression 24 h after transfection. 
The corresponding phase micrographs are B and D, respectively. 
Note that there is no apparent association with microfilament  bun- 
dies in the transfected  cells expressing low (A) medium or high (C) 
levels of CAD40. Bar equals 10/zm. 
High Amounts of CAD39 and CAD40  Are Expressed in 
Stable CHO Cell Lines 
To better examine the consequences of CAD39 and CAD40 
expression in CHO cells, we generated stable lines of clones 
expressing either fragment. After drug selection, single cell 
isolation, and expansion, we tested the cell lines for expres- 
sion level by Western blot analysis, and for localization via 
immunofluorescence microscopy, The immunofluorescence 
distribution of expressed CAD39 or CAD40 in the cells from 
stable clones was the same as described for the transient 
transfection experiments (see Fig. 2 for CAD39 and Fig. 3 
for CAD40). Both sets of stable lines have morphologies in- 
distinguishable from parent CHO cells. Of the stable CAD39 
and CAD40 lines examined, there were no apparent expres- 
sion-related changes in cell shape, size, or overall microfila- 
ment organization (see Fig. 9 for CAD39 lines). 
A quantitative analysis of CAD39 line expression levels, 
relative  to  endogenous  caldesmon and  to  each  other,  is 
shown in Table I. Known quantities of CAD39 line total cell 
extracts and purified CAD39 protein  standards were sub- 
jected to Western blot analysis with C21  antibody. Auto- 
radiograph band  intensities were obtained using Image-l~ 
AT  image  analysis  software,  and  protein  amounts  were 
quantified  using  a  standard  curve  constructed  from  the 
purified CAD39 band intensities. The Table I results show 
that all stable lines express very low levels of CHO caldes- 
mon,  that clones 39L12,  39Cll,  and 39C15  express  16.3, 
73.4, and 78.9 times more CAD39 than endogenous caldes- 
mon,  respectively,  and  that  39C5,  our  non-expressing, 
G418-resistant control expresses no CAD39. Monoclonal an- 
tibody C21  was used in this analysis because it recognizes 
an epitope, aa. 480-529 of human fibroblast caldesmon, that 
is  conserved with 96%  identity between human,  rat and 
chicken caldesmon (Novy et al., 1991), and C21 does recog- 
nize CHO caldesmon to the same extent that it recognizes 
CAD39. To confirm that the differences seen between endog- 
enous caldesmon levels and expressed CAD39 were not due 
to  properties  peculiar  to  C21,  we  used  polyclonal anti- 
caldesmon antibodies (Bretscher and Lynch, 1985) to stain 
control and  CaD39-expressing  cells  (data not shown).  A 
Western blot demonstrating the negative, low, medium-high, 
and high levels of CAD39 expression in the stable lines is 
shown in Fig. 4 B:  39C5  (lane/),  39L12 (lane 2),  39Cll 
(lane 3), and 39(215 (lane 4). The relative levels of CAD40 
expression in the selected CAD40 stable clones were also 
analyzed by immunoblotting. Antibody C57 (Fig. 5 A) was 
used to detect the CAD40, and clones 40N2 (lane 5), 40C11 
(lane 4), 40C22 (lane 2), 40C7 (lane 3), and 40C17 (lane/) 
were chosen to represent negative control, low,  medium, 
medium-high, and high CAD40 levels. The purified, bacteri- 
ally produced CAD40 fragment,  included to  demonstrate 
CAD40 size and C57 immunospecificity, is shown in Fig. 5 
A (lane pETCaD40). 
Low M, Tropomyosin Levels Increase with Increasing 
Levels of  CAD39 Expression 
When immunoblots of stable CAD39 lines (Fig. 4  C) and 
CAD40 lines (Fig. 5 B) were probed with CG3 for endoge- 
nous TM5, an interesting phenomenon was observed. Fig. 
4  demonstrates  that  CAD39 lines  contain  an  increased 
amount of detectable TM that roughly parallels the amount 
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sis of CAD39 lines 39C5 (lane 
I),  39L12  (lane  2),  39Cll 
(lane 3),  and 39C15  (lane 4) 
was done in  duplicate to re- 
veal the steady state levels of 
CAD39 and endogenous CHO 
caldesmon with C21 antibody 
(B) and the level of endoge- 
nous low Mr TMs with CG3 
antibody (C). There is no ex- 
pression  of CAD39  in  39C5 
cells (B, lane 1) and increas- 
log  levels  of CAD39  expres- 
sion in 39L12 (lane 2), 39Cll 
(lane 3), and 39C15  (lane 4). 
Notice that the amount of TM 
detected  is  increased  in  the 
CAD39 lines, roughly parallel 
to  CAD39  expression  levels 
(compare to lanes 1-4 of  panel 
C).  The amido-black-stained 
panel A  shows the total pro- 
tein  loedings  for  the  corre- 
sponding Western blots.  C21 
recognition  of  endogenous 
caldesmon in panel B reveals 
that  there  is  no  apparent 
change  in  caldesmon  levels 
(panel  B,  lanes  1-4). 
CHOCaD; CHO endogenous 
caldesmon. 
of CAD39  expressed  (compare the lanes in panel 4  B  with 
the corresponding  lanes in panel 4  C).  This is not seen in 
CaD40-expressing lines (Fig. 5) where steady-state levels of 
TM5  are  unchanged  across  all  four  CAD40  lines  and  the 
negative control  (compare the anti-CaD40  blot in Fig.  5  A 
to the anti-TM panel in Fig.  5 B).  The increase in endoge- 
nous TM5 levels, therefore, appears to be specific to CAD39 
expression.  Additionally,  CAD39 or CAD40 overexpression 
does not appear to have an effect on CHO caldesmon as lev- 
els of endogenous caldesmon are unaltered in stable lines ex- 
Figure 5.  Western blot analy- 
sis of CaD40-expressing lines 
40C17,  40C22,  40C7,  and 
40C11 as well as negative con- 
trol  line  40N2  and  purified, 
bacterially expressed  CAD40 
fragment,  pETCaD40  is 
shown. The blots were probed 
with C57 antibody for CAD40 
(A), CG3 antibody for endog- 
enous  low Mr  TM  (B),  and 
C21  (250X  dilution)  for en- 
dogenous caldesmon (C). The 
amido  black-stained  panel 
shows  the  relative total  pro- 
tein loaded. Note that endoge- 
nous TM and caldesmon lev- 
els do not change relative to 
CAD40  expression  in  the 
CAD40  lines  (compare lanes 
in panels B and C to the same 
lanes  in  panel  A).  The  fast 
migrating band recognized by 
C21  in panel C is a degrada- 
tion  product  of  caldesmon. 
CHOCaD; endogenous CHO 
caldesmon. 
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The fast-migrating species recognized by C21 in Fig. 5 C is 
a degradation product of CHO caldesmon often detectable 
in long exposures. 
CaD39-Specific  Increase in TM Steady-State Levels Is 
Not Due to Increased TM Synthesis 
A  comparison of the pulse-labeled protein profiles for all 
four CAD39 lines revealed no differences in the amount of 
low Mr TM protein synthesized during the 4 h label incor- 
poration.  Fig.  6  shows the result of two-dimensional gel 
electrophoresis  on  total  extracts  from  [35S]methionine- 
labeled negative control cell line, 39C5 (Fig. 6 A), and high- 
expressing line 39C15 (Fig. 6 B). The two small arrowheads 
indicate the positions of endogenous low Mr TM isoforms, 
TM4 and TM5.  The identification of TM4 and TM5 was 
based  on  two-dimensional gel  immunoblotting and  two- 
dimensional  gel  analysis  of heat-resistant  microfilament 
fractions (data not shown). This data suggests that increased 
steady-state levels of TM detected by immunoblotting (Fig. 
4  C) are due to accumulation of protein rather than an in- 
crease in TM production. We also examined the message 
levels  of TM4  and  TM5  in  CaD39-expressing  lines  by 
Northern blot analysis. Again, no differences in TM mRNA 
levels were detected (data not shown), adding to the sugges- 
tion that TM protein is stabilized and accumulates in CHO 
cells which express CAD39. 
CAD39 Expression Decreases the Rate of  Low Mr TM 
Protein Turnover 
To more directly address the question of whether TM pro- 
rein is stabilized in CaD39-expressing cells, we performed 
pulse-chase experiments on stable CAD39 cell lines. Cells 
from  non-expressing  39C5  and  high-CaD39-expressing 
39C15 lines were pulse-labeled 25 min, and then chased for 
0, 2, 6,  10,  14,  and 22 h before harvesting. The [35S]me- 
thionine-labeled total cell extracts were separated by two- 
dimensional gel electrophoresis,  processed for fluorogra- 
phy, and the corresponding autoradiographs were analyzed 
for gel spot intensity (see Materials and Methods). Fig. 7 
shows the result of plotting gel spot intensity values against 
the chase time for TM4 (A) and TM5 (B). A comparison of 
the plots  from 39C5  and 39C15  reveals a  significant de- 
crease in the protein turnover rates for both TM4 and TM5 
in the CaD39-expressing  cells.  The estimated 39C5  half 
lives for TM4 (10 h) and TM5 (5 h) are significantly differ- 
ent from TM half lives seen in 39C15 cells (22 h for TM4 
and 17 h for TM5). Similar results were obtained from mul- 
tiple two-dimensional gel runnings for a single pulse-chase 
experiment, as well as with a separate pulse chase experi- 
ment which used a shorter pulse-labeling period. The turn- 
over rate for a randomly selected control protein was not 
different in 39C5 and 39C15 lines (data not shown). 
CAD39 Expression Stabilizes Microfilaments 
To investigate the consequence of overexpression of CAD39 
and  elevation  of  endogenous  TM  levels  on  the  fate  of 
microfilaments, TM-enriched microfilament fractions were 
isolated from CHO cells (Fig. 8 A) and the CAD39 clones 
(Fig.  8 B) by a previously developed method (Lin et al., 
1984).  The results of a microfilament isolation from CHO 
cells are shown in Fig. 8 A, a Coomassie blue-stained gel of 
the microfilament  fraction (lane 1 ), the heat-treated superna- 
tant (lane 2), and the heat-treated pellet (lane 3). Note that 
CHO cells contain low Mr TM isoforms, TM4 and TM5, 
but not high Mr isoforms, TM2 or TM3. They do possess a 
Figure 6. Two dimensional gel analysis of 3sS-labeled total cell extracts from negative control line, 39C5 and high expression line, 39C15. 
Cells were labeled for 4 h, and then harvested and subjected to two-dimensional  gel electrophoresis. The results of a 3-d autoradiograph 
exposure for each are shown. The amount of low Mr TMs, CHO TM4, and TM5 (protein spots indicated by small arrowheads), synthe- 
sized during incubation with 3sS-label, does not appear to be different in the two cell lines. 
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Figure  7.  Pulse-chase  analysis  of low  Mr  TM  turnover  rates  in 
39125 and 39C15 cell lines. Cells from non-expressing 39C5 and 
high-CaD39-expressing 391215 lines  were pulse-labeled 25  rain 
with [35S] methionine, and then incubated in chase media before 
harvest. Cell extracts from six chase time points were subjected to 
two-dimensional gel electrophoresis  and the autoradiographs  were 
analyzed for relative gel spot intensity. The graphs demonstrate the 
TM4 (,4)  and TM5 (B) spot intensity values over chase time for a 
representative experiment, one of two. Note the decreased turnover 
rate for both low Mr TMs  in the CaD39-expressing  39C15  cells. 
Table II. Amounts of TM-enriched Microfilaments Isolated 
from  Various CAD39 Expressing Cell lines 
% of total actin in 
Cell lines  TM-enriched  microfllaments 
39C5  7.60 
39L12  7.92 
39Cll  11.17 
39C15  11.30 
Amounts of [35S]methionine  incorporation into the actin band of each fraction 
were used for calculation of percent. The data are from a representative experi- 
ment, one of two. 
Resistance to Cytochalasin B Disruption Parallels 
CAD39 Expression 
Cytochalasins are fungal toxins which can shift the overall 
microfilament organization in treated cells from a stress fiber 
network, to short fragments in focal accumulations.  Cyto- 
chalasins  act by  binding  actin  filament barbed ends,  thus 
inhibiting filament growth and also, possibly, filament inter- 
protein that has the apparent size (indicated with an asterisk) 
of a  TM1,  but this protein does not  show heat-stability,  a 
characteristic property of TM (compare Fig. 8 A; lanes I and 
2).  To quantify  the mierofilaments from the CAD39  lines, 
cells were labeled in vivo for 16 h with [35S]methionine  be- 
fore isolation of TM-enriched  mierofilaments.  Aliquots  of 
samples from each step of the isolation procedure were ana- 
lyzed on SDS-PAGE. The actin bands of each fraction were 
cut out and their radioactivity quantified by a liquid scintilla- 
tion counter.  The yield of isolated microfilaments was calcu- 
lated and expressed as percent of total actin. As can be seen 
in  Table  II,  high-expressing  cells,  39Cll  and  39C15,  ap- 
peared to have significantly higher amounts of TM-enfiched 
microfilaments. This increase is also apparent in the Fig. 8 
B autoradiograph  from SDS-PAGE resolution of microfila- 
ment fractions from 39C5  (lane/),  39L12  (lane 2),  39Cll 
(lane 3),  and 39C15  (lane 4).  These data  suggest that the 
stabS,  endogenous  TM,  together  with  overexpressed 
CAD39  protein, can further stabilize microfilaments inside 
the cell. On the other hand, the CaD39-stabilized microfila- 
ment may protect endogenous  TM  from turnover,  thereby 
resulting in CaD39-expressing  clones which contain more 
endogenous TM. 
Figure 8.  TM-enriched  microfilaments were prepared from CHO 
cells  (,4)  and CAD39 lines  (B). The Coomassie blue-stained gel 
from the ClIO microfilament fraction (A, lane 1), the heat-treated 
supernatant (lane 2) and the heat-treated pellet (lane 3) indicates 
the presence of microfilament-assoeiated low Mr TM  isoforms, 
TM4 and TM5,  as well as a protein (*) which has the apparent Mr 
of a TM1,  but is not heat-resistant  (compare lanes 1 and 2).  CHO 
cells  do  not have high Mr TM  isoforms,  TM2  or TM3.  The an- 
toradiograph shown in B is from [3SS]methionine-labeled micro- 
filament fractions  from 39C5  (B,  lane 1),  39L12  (lane 2),  39Cll 
(lane 3), and 391215 (lane 4) cells. Note the increase in actin, TM4 
and TM5,  that roughly parallels the amount of CAD39 present in 
these microfilament fractions. 
Warren et al. Regulation of Actin Microfilament Stability  365 Figure 9. CaD39-expressing  lines display resistance to a 30-rain cytochalasin B treatment of 1.25/~g/ml.  Immunofluorescence microscopy 
with CG3 identifies the TM-containing microfilament bundles in CAD39 lines exposed to DMSO alone (,4, B, C, and D) or to cytochalasin 
B dissolved in DMSO (E, F, G, and H). In the absence of cytochalasin B, there are no obvious differences  in the cell morphology, size, 
shape,  and microfilamant  organization of the CAD39 cell lines 39C5 (A),  39L12  (B), 39Cll  (C), and 39C15  (D).  After exposure to 
cytochalasin B, non-expressing  39C5 (E) cells have virtually no intact TM-containing filament bundles after exposure to cytochalasin B, 
whereas 39L12 (F), 39Cll (G), and 39C15 (H) cells increasingly show more resistant microfilament bundles and fewer focal aggregations. 
Bar equals  10/~m. 
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(Cooper,  1987).  If CAD39 expression in CHO cells does 
stabilize TM-containing microfilament bundles, we hypoth- 
esized that CAD39 expression might confer resistance to 
cytochalasin B. Cells from each CAD39 line were grown on 
glass coverslips, treated to 1.0, 1.25, or 1.5 #g/ml cytochala- 
sin B, or DMSO alone, and stained with CG3 to visualize 
the remaining TM-containing microfilament bundles in the 
cells. We discovered that CAD39 expression did render the 
CAD39 lines less sensitive to the effects of cytochalasin B. 
Under the control treatment (DMSO alone) 39C5 (Fig. 9 A), 
39L12 (Fig. 9 B), 39Cll (Fig. 9 C), and 39C15 (Fig. 9 D) 
ceils display a microfilament organization characteristic of 
CHO cells. An automatic exposure meter was used to take 
the micrographs, therefore no TM staining intensity differ- 
ences are seen.  Fig. 9 micrographs E-H show the results 
from cells exposed 30 min to 1.25 #g/ml cytochalasin B, the 
concentration which best demonstrates the graded response 
to cytochalasin. The non-expressing line 39C5 (Fig. 9 E), 
displays an almost complete filament rearrangement into fo- 
cai aggregations. Low and medium-high expressors, 39L12 
(Fig. 9 F) and 39Cll (Fig. 9 G), show intermediate effects, 
and cells from high expressing line 39C15 (Fig. 9 H) demon- 
strate resistant, partially intact stress fiber networks. Treated 
cells, examined with rhodamine-phalloidin for F-actin stain- 
ing, had  identical  filament  staining  patterns  (data  not 
shown). CAD39 expression also conferred increased resis- 
tance to Triton X-100 (data not shown), suggesting that the 
cortical cytoskeleton is also stabilized. 
Discussion 
The proposed role of caldesmon in the regulation of fibro- 
blast microfilament stability is supported by several reports 
describing in vitro observations. In vitro analysis of caldes- 
mon's interactions with actin and TM revealed that caldes- 
mon can stimulate actin polymerization (Galazkiewicz et al., 
1989) and greatly enhance TM's binding to actin (Yamashiro- 
Matsumura and Matsumura, 1988; Novy et al., 1993b). Cal- 
desmon was also found to protect actin filaments from gelso- 
lin severing and to augment reannealing of fragmented actin 
filaments (Ishikawa et al.,  1989a,b). 
The in vivo functions of nonmuscle caldesmon have not 
been well characterized, but several lines of correlative in 
vivo evidence have also  suggested that caidesmon might 
stabilize microfilaments. In the fibroblast cell, ealdesmon 
does localize to actin and TM-rich stress fibers and ruffle 
regions (Lin et al., 1988; Dingus et al., 1986; Bretscher and 
Lynch, 1985; Owada et al., 1984). In cells which have stabi- 
lized and thickened microfilament bundles after dexametha- 
sone treatment, steady-state levels, of caldesmon (but not ac- 
tin, TM, or gelsolin) was shown to be increased (Castellino 
et al., 1992). In addition, caldesmon is found to be reduced 
or dissociated from microfilaments in cells that do not dis- 
play a hearty cytoskeleton. For example, caldesmon is phos- 
phorylated and subsequently released from microfilaments 
in mitotic cells actively dissolving their actin filament bun- 
dies (Yamashiro et al., 1990; Hosoya et al., 1993).  Also, in 
transformed cells which exhibit a diminished and diffuse ac- 
tin cytoskeleton, caldesmon expression  is  downregulated 
(Novy et al., 1991; Owada et al., 1984).  We are seeking to 
further understand the stabilizing role of nonmuscle caldes- 
mon and, in this paper, provide direct evidence for the first 
time,  that the actin-,  TM-,  and Ca++/Calmodulin-binding 
COOH-terminal  fragment of human fibroblast caldesmon 
can stabilize TMs and microfilament bundles in vivo. 
In the stably transfeeted CAD39 lines, we see an increase 
in the steady-state level of endogenous TM5. The fact that 
the TM5 increase is not due to increased TM synthesis, sug- 
gests that this TM is somehow protected from normal protein 
turnover. Pulse-chase experiments have confirmed that TM5 
as well as TM4 turn over more slowly in CaD39-expressing 
39C15  cells. This protection of both low M, TM isoforms 
likely involves CaD39-enhanced TM binding to F-actin. We 
have previously characterized bacterially expressed CaD39's 
ability to enhance low M, TM binding to F-actin (Novy et 
al.,  1993b),  and have shown in this report that CAD39 ex- 
pressed in CHO cells localizes to stress fibers and ruffles, 
and  is  a  component of isolated,  TM-enriched  microfila- 
merits.  The amount of aetin isolated in our microfilament 
preparations is also increased, suggesting further that inter- 
actions between TM and actin filaments are stabilized. The 
enhanced accumulation of TM appears to be a phenomenon 
specific to CAD39 stable clones, as levels of endogenous cal- 
desmon are not altered in CAD39 lines, and levels of TM are 
not altered in CalM0-expressing lines. We have also exam- 
ined  endogenous  caldesmon  steady-state levels  in  stable 
CHO lines which express mouse skeletal/~TM. No changes 
in caldesmon levels were seen (data not shown), even though 
force-expressed/TrM readily assembles onto CHO micro- 
filaments (Warren and Lin,  1993).  A hierarchy of interac- 
tions is  suggested here,  in that overexpression of CAD39 
leads to an accumulation of TM, but overexpression of TM 
does not affect steady-state levels of caldesmon. 
In support of an actual stabilization of microfilament bun- 
dies, we also found that CAD39 expression confers, upon ex- 
pressing cells, enhanced resistance to cytochalasin B disrup- 
tion and Triton extraction. Consistent with our observations 
that CaD39-expressing lines possessed more intact micro- 
filament bundles after exposure to cytochalasin B, Castellino 
et al. (1992) reported that cells with dexamethasone induced 
caldesmon overexpression, were also less susceptible to cy- 
tochalasin disruption. Cytochalasins are thought to possibly 
act by destabilizing actin filament interactions with capping 
proteins important for holding filaments in place. Stress fibers 
have also been seen to contract upon cytochalasin treatment, 
as if released from their attachments (Cooper,  1987). CaD39- 
associated protection may be a combined response to stabi- 
lized filaments, stabilized attachments, and an inhibited con- 
traction response.  That these CaD39-expressing cells are 
also resistant to a Triton X-100 treatment strong enough to 
completely collapse the cytoskeleton of non-expressing  cells, 
supports the notion that microfilament and microfilament- 
membrane attachments are stabilized. In addition, prelim- 
inary analysis of these CAD39 lines has indicated that their 
ability to attach to substrate is also enhanced. Further stud- 
ies on the effect of CAD39 overexpression on cell attachment 
and spreading on different substrata are currently underway. 
We did not observe expression-related alterations in the 
size, shape, or microfilament organization of the CAD39 cell 
lines (see Fig. 9), even though the estimated levels of CAD39 
reached up to 79 times that of endogenous caldesmon. One 
could argue that CAD39, a  fragment of caldesmon, might 
regulate, and/or be regulated, differently than intact caldes- 
mon.  Unfortunately, using the pCB6hx expression vector, 
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We are currently working towards an inducible expression 
of full-length  caldesmon to address this important issue. It 
is important to note, however, the findings of Yamakita et al. 
(1990), that microinjection  of intact gizzard caldesmon into 
fibroblasts did not alter cell morphology or the actin cyto- 
skeleton, even though the gizzard caldesmon remained in- 
corporated into stress fibers and ruffle regions for days after 
injection.  Additionally,  microinjected  COOH-terminal  cal- 
desmon fragment  behaved  indistinguishably  from injected 
full-length  gizzard caldesmon (Yamakita et al.,  1990). 
The approach of artificially  expressing a given protein in 
cultured cells,  and observing the resultant phenotype,  has 
been used to examine the norms! roles for proteins  such as 
vlllin (Friederich et al., 1989L gelsolin (Cunningham et al., 
1991),  and vinculin (Rodriguez Fernandez et al.,  1992), to 
name a few. In this paper, we have used transfection mediated 
expression of caldesmon fragments to study nonmuscle cal- 
desmon function. As mentioned earlier, the expression effects 
of the CAD39 fragment may not fully represent the conse- 
quences of overexpressing  full length caldesmon. However, 
since caldesmon itself has been implicated  in microfilament 
stability, CHO-expressed CAD39 and microinjected  COOH- 
terminal  gizzard  caldesmon  fragment  (Yamakita et  al., 
1990) are able to localize to the same structures as endog- 
enous caldesmon, and COOH-terminal  gizzard caldesmon 
fragment (Marston and Redwood, 1993) and bacterially pro- 
duced CAD39 (Novy et al., 1993b) were shown to retain the 
properties,  in vitro,  of whole caldesmon,  we feel that the 
CaD39-mediated stabilization  of the actin cytoskeleton is a 
valid indication of one function of caldesmon in nonmuscle 
cells. We are currently exploring other caldesmon functions 
in our CAD39 stable lines with experiments  analyzing  cell 
motility. 
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